- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Assisted Reproductive Technology; Anovulatory infertility; Infertility.
- Meeting Date: July 2021
- Public Summary Document (PSD) July 2021 PBAC Meeting - (PDF 1012KB)
- Public Summary Document (PSD) July 2021 PBAC Meeting - (Word 73KB)
Follitropin alfa – July 2021
Follitropin alfa: Injection 300 I.U. in 0.5 mL multi-dose cartridge, Injection 450 I.U. in 0.75 mL multi-dose cartridge, Injection 900 I.U. in 1.5 mL multi-dose cartridge; Ovaleap®
Last updated
29 October 2021
